Model
Edge
Lineage Cell Therapeutics
0001310683
Filing Type
4
Filing Date
3/9/2023
Updated
3/10/23, 12:03 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership